"Among the 5–11-year-olds, 36% were diagnosed with MIS-C," the authors wrote. "These results suggest that while older ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Looking at options history for Moderna MRNA we detected 21 trades. If we consider the specifics of each trade, it is accurate ...

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

Syringes are expected to dominate the market as the highest revenue-generating segment. The report forecasts that the ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...

It is best to optimize the seasonal vaccines and therefore may administer the COVID-19 vaccine and the influenza vaccine on ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

Zymeworks has dosed the first subject in a Phase I trial of ZW171 to treat ovarian cancer, non-small cell lung cancer and ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...